RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas. (Q53478339)
Jump to navigation
Jump to search
scientific article published on 19 October 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas. |
scientific article published on 19 October 2015 |
Statements
RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas (English)
César Serrano
Cleofé Romagosa
Sara Simonetti
Claudia Valverde
Teresa Moliné
Rosa Somoza
Manuel Pérez
Ramona Vergés
Rosa Domínguez
19 October 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference